P-MEC China
The pharma technology zone within CPhI China, P-MEC China focuses on equipment, machinery, packaging, analysis and technology, and is an integral part of Asia?s largest annual networking event for the pharmaceutical community. Held alongside CPhI China for pharmaceutical ingredients and APIs, ICSE for contract services and BioPh for biopharmaceutical solutions, P-MEC China is expected to attract over 20,000 visitors, including 7,000 from outside of China.
June 24, Shanghai New International Expo Centre
Providing an international platform for companies involved in an array of pharmaceutical production and analysis activities, P-MEC China is a highly targeted, pharma focused event, which brings together buyers and specifiers from more than 100 countries in conjunction with its collocated shows.
P-MEC has evolved in line with industry demand to include instrumental analysis, measuring and testing technology, materials testing, quality control, laboratory equipment as well as the traditional, large-scale capital equipment for which P-MEC is well known.
The domestic market in China for pharmaceuticals is already huge, yet it continues to grow, and there is an increasing need for high-value chemicals and contract services. There is also significant demand for innovative, high-quality equipment and machinery, particularly if it is ISO certified.
With all fields of the pharma industry gathered under one roof, and an extended conference programme, all the ingredients of success will be there. Join us at P-MEC China to discover the latest developments and innovations across every aspect of Pharma and Biotech Equipment, Laboratory and Analytical techniques while experiencing the unique face-to-face networking opportunities that only Asia’s largest pharmaceutical networking event can provide.
Take your share of the growth in China’s pharma market.
Register for free at www.pmec-china.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Adding SYLOID® Mesoporous Silica to Improve Run Time and Yield for Micronization Processes
May 9th 2025A must-read for anyone in the industry looking to enhance their micronization processes. Discover how adding low percentages of SYLOID® mesoporous silica can significantly improve the run time and yield of jet milling processes for hard-to-process Active Pharmaceutical Ingredients (APIs). Imagine achieving a more consistent feed rate and a homogenous final product simply by pre-blending SYLOID® mesoporous silica with your APIs. Grace & Microsize conducted experiments that reveal substantial improvements in both run time and yield, making this paper an essential guide for professionals aiming to optimize their manufacturing processes and boost efficiency and feed rate consistency.
